12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement in Wednesday's intraday session. Kura Oncology (KURA) led the gainers with a 48.1% rise, while Annovis Bio (ANVS) saw the largest drop among the losers, falling 19.2%. Other notable movers included Telesis Bio (TBIO), Ensysce Biosciences (ENSC), and Inhibikase Therapeutics (IKT) with substantial gains, and Sight Sciences (SGHT), Gyre Therapeutics (GYRE), and Curis (CRIS) with notable losses.
January 24, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Annovis Bio stock declined 19.2% to $9.4, with a market cap of $96.4 million.
The significant drop in Annovis Bio's stock price indicates negative market sentiment, which could persist in the short term.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Ensysce Biosciences stock climbed 25.87% to $1.75, with a market cap of $5.5 million.
Ensysce Biosciences' stock price jump may lead to increased investor interest, potentially sustaining the upward trend in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Inhibikase Therapeutics stock increased by 21.86% to $2.62, with a market cap of $16.1 million.
The rise in Inhibikase Therapeutics' stock price reflects positive investor sentiment, which could lead to further short-term appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Kura Oncology stock surged 48.1% to $19.87, with a market cap of $1.4 billion.
The substantial increase in Kura Oncology's stock price suggests positive investor sentiment and could lead to continued short-term momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Telesis Bio stock rose 34.87% to $0.42, with a market cap of $12.5 million.
Telesis Bio's significant stock price increase could attract more attention, potentially leading to further short-term gains.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100